BOK Financial’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,232
Closed -$36.3K 1501
2024
Q2
$36.3K Hold
2,232
﹤0.01% 890
2024
Q1
$31K Sell
2,232
-803
-26% -$11.2K ﹤0.01% 884
2023
Q4
$31.7K Hold
3,035
﹤0.01% 852
2023
Q3
$26K Buy
3,035
+761
+33% +$6.53K ﹤0.01% 822
2023
Q2
$17.1K Buy
2,274
+2,000
+730% +$15.1K ﹤0.01% 886
2023
Q1
$2.43K Buy
+274
New +$2.43K ﹤0.01% 1102
2019
Q2
Sell
-12,114
Closed -$190K 934
2019
Q1
$190K Sell
12,114
-3,458
-22% -$54.2K ﹤0.01% 867
2018
Q4
$240K Sell
15,572
-4,893
-24% -$75.4K 0.01% 782
2018
Q3
$441K Sell
20,465
-945
-4% -$20.4K 0.01% 713
2018
Q2
$520K Buy
21,410
+1,630
+8% +$39.6K 0.01% 657
2018
Q1
$338K Sell
19,780
-21,025
-52% -$359K 0.01% 738
2017
Q4
$773K Buy
40,805
+18,809
+86% +$356K 0.02% 550
2017
Q3
$387K Buy
21,996
+2,158
+11% +$38K 0.01% 725
2017
Q2
$659K Buy
19,838
+888
+5% +$29.5K 0.02% 562
2017
Q1
$608K Sell
18,950
-1,415
-7% -$45.4K 0.02% 612
2016
Q4
$739K Sell
20,365
-2,503
-11% -$90.8K 0.02% 540
2016
Q3
$1.05M Buy
22,868
+521
+2% +$24K 0.03% 467
2016
Q2
$1.12M Sell
22,347
-989
-4% -$49.7K 0.04% 421
2016
Q1
$1.25M Sell
23,336
-6,559
-22% -$351K 0.05% 383
2015
Q4
$1.96M Buy
29,895
+2,947
+11% +$193K 0.07% 307
2015
Q3
$1.52M Sell
26,948
-24,035
-47% -$1.36M 0.06% 340
2015
Q2
$3.01M Buy
50,983
+5,077
+11% +$300K 0.1% 232
2015
Q1
$2.86M Buy
45,906
+11,450
+33% +$713K 0.1% 248
2014
Q4
$1.98M Sell
34,456
-8,197
-19% -$472K 0.07% 298
2014
Q3
$2.29M Buy
42,653
+659
+2% +$35.4K 0.08% 280
2014
Q2
$2.2M Buy
41,994
+24,483
+140% +$1.28M 0.07% 296
2014
Q1
$925K Sell
17,511
-214
-1% -$11.3K 0.03% 458
2013
Q4
$710K Sell
17,725
-18,666
-51% -$748K 0.02% 524
2013
Q3
$1.38M Sell
36,391
-212
-0.6% -$8.01K 0.05% 359
2013
Q2
$1.43M Buy
+36,603
New +$1.43M 0.05% 329